Compound Detail
CHEMBL591118
CARMEGLIPTIN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2
Basic Information
| ChEMBL ID | CHEMBL591118 |
| Name | CARMEGLIPTIN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | GUYMHFIHHOEFOA-ZCPGHIKRSA-N |
1
Targets
2
Activities
1
Assay Types
6
PK Parameters
12
Publications
7
Known Names
1
Indications
1
Mechanisms
Molecular Properties
377.5
MW (Da)
1.52
ALogP
5
HBA
1
HBD
68.0
PSA (Ų)
0.86
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dipeptidyl peptidase IV inhibitor | INHIBITOR | Dipeptidyl peptidase 4 | ✓ | ✓ |
Indications
Diabetes Mellitus, Type 2
Activity Summary
IC50 2 meas. best 8.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 CHEMBL284 | IC50 | 8.17 | 8.17 | 6.8 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 24.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 8.5 | mL.min-1.kg-1 | Macaca fascicularis |
| F | 28.0 | % | Rattus norvegicus |
| F | 33.0 | % | Macaca fascicularis |
| T1/2 | 5.3 | hr | Rattus norvegicus |
| T1/2 | 6.8 | hr | Macaca fascicularis |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 | IC50 | = | 6.8 | nM | 8.17 | Inhibition of human DPP4 | 20031405 |
| Dipeptidyl peptidase 4 | IC50 | = | 6.8 | nM | 8.17 | Inhibition of dipeptidyl peptidase 4 (unknown origin) | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Rattus norvegicus | 8 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Cynomolgus monkey | 6 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Unchecked | 4 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Mus musculus | 2 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Dipeptidyl peptidase 4 | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | No relevant target | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | ADMET | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Phospholipidosis | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Canis familiaris | 1 |
| 20031405 | 10.1016/j.bmcl.2009.12.024 | Rhesus monkey | 1 |
| - | 10.1007/s00044-012-0455-6 | Dipeptidyl peptidase 4 | 1 |
Data from ChEMBL 36 via Core Engine